Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat

Brain Research Bulletin

Volumn 77, Issue 5, 2008, Pages 312-319

  Grealish, Shane ^a,b   Xie, Lan ^a   Kelly, Maebh ^a   Dowd, Eilís ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b LUND UNIVERSITY   (Sweden)

Author keywords

6 Hydroxydopamine; Animal models; Medial forebrain bundle; Motor function; Parkinson's disease; Striatum

Indexed keywords

NEUROTOXIN; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NERVE FIBER; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STRIATONIGRAL DEGENERATION;

ADRENERGIC AGENTS; ANIMALS; AXONS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; HUMANS; MALE; MOTOR ACTIVITY; NERVE DEGENERATION; NEUROPSYCHOLOGICAL TESTS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, INBRED STRAINS; SUBSTANTIA NIGRA; TIME FACTORS;

EID: 54549119458     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.08.018     Document Type: Article

References (29)

1. Berger K., Przedborski S., and Cadet J.L. Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats. Brain Res. Bull. 26 (1991) 301-307
2. Blandini F., Levandis G., Bazzini E., Nappi G., and Armentero M.T. Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model. Eur J. Neurosci. 25 (2007) 397-405
3. Bowenkamp K.E., Hoffman A.F., Gerhardt G.A., Henry M.A., Biddle P.T., Hoffer B.J., and Granholm A.C. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol. 355 (1995) 479-489
4. Cadet J.L., Last R., Kostic V., Przedborski S., and Jackson-Lewis V. Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen. Brain Res. Bull. 26 (1991) 707-713
5. Deumens R., Blokland A., and Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 175 (2002) 303-317
6. Dowd E., Monville C., Torres E.M., and Dunnett S.B. The Corridor Task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum. Brain Res. Bull. 68 (2005) 24-30
7. Fitzsimmons D.F., Moloney T.C., and Dowd E. Further validation of the corridor task for assessing deficit and recovery in the hemi-Parkinsonian rat: restoration of bilateral food retrieval by dopamine receptor agonism. Behav. Brain Res. 169 (2006) 352-355
8. Harkin A., Connor T.J., Mulrooney J., Kelly J.P., and Leonard B.E. Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats. Life Sci. 68 (2001) 1367-1382
9. Hoffer B.J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L.F., and Gerhardt G.A. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182 (1994) 107-111
10. Hokfelt T., and Ungerstedt U. Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurones: an electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system. Brain Res. 60 (1973) 269-297
11. Ichitani Y., Okamura H., Matsumoto Y., Nagatsu I., and Ibata Y. Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum. Brain Res. 549 (1991) 350-353
12. Ichitani Y., Okamura H., Nakahara D., Nagatsu I., and Ibata Y. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra. Exp. Neurol. 130 (1994) 269-278
13. Kirik D., Rosenblad C., and Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp. Neurol. 152 (1998) 259
14. Lapchak P.A., Miller P.J., Collins F., and Jiao S. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery. Neuroscience 78 (1997) 61-72
15. Lee C.S., Sauer H., and Bjorklund A. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat. Neuroscience 72 (1996) 641-653
16. Olsson M., Nikkhah G., Bentlage C., and Bjorklund A. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J. Neurosci. 15 (1995) 3863
17. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., and Togasaki D.M. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 67 (1995) 631-647
18. Rosenblad C., Kirik D., and Bjorklund A. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Exp. Neurol. 161 (2000) 503
19. Sauer H., and Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59 (1994) 401-415
20. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., and Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, Parkinsonism and spinal cord injury. Neuropharmacology 39 (2000) 777-787
21. Schallert T., Norton D., and Jones T.A. A clinically relevant unilateral rat model of Parkinsonian akinesia. J. Neural Transpl. Plast. 3 (1992) 332
22. Schultz W. Behavioral dopamine signals. Trends Neurosci. 30 (2007) 203-210
23. Schwarting R.K., and Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog. Neurobiol. 50 (1996) 275-331
24. Schwarting R.K., and Huston J.P. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog. Neurobiol. 49 (1996) 215-266
25. Torres E.M., Monville C., Gates M.A., Bagga V., and Dunnett S.B. Improved survival of young donor age dopamine grafts in a rat model of Parkinson's disease. Neuroscience 146 (2007) 1606-1617
26. Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5 (1968) 107-110
27. Ungerstedt U. Histochemical studies on the effect of intracerebral and intraventricular injections of 6-hydroxydopamine on monoamine neurons in the rat brain. In: Malmfors T., and Thoenen H. (Eds). 6-Hydroxydopamine and Catecholaminergic Neurons (1971), North-Holland Publishing Company
28. Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol. Scand. Suppl. 367 (1971) 1-48
29. Ungerstedt U., and Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24 (1970) 485